Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) are related viruses causing significant respiratory illnesses.
• Palivizumab, a monoclonal antibody (mAb) targeting the RSV F protein, is used to prevent severe RSV infections.
• Previous studies identified hMPV F protein-specific mAbs with in vitro and in vivo neutralizing activity.

Purpose of the Study:

• To generate hMPV mAb-resistant mutants (MARMs) to identify neutralizing epitopes on the hMPV F protein.
• To compare the identified hMPV epitopes with known epitopes on the RSV F protein.

Main Methods:

• Generation of hMPV MARMs by exposing the virus to neutralizing mAbs.
• Sequencing of the F proteins from hMPV MARMs to identify mutations.
• Mapping of neutralizing epitopes on the hMPV F protein based on mutation sites.

Main Results:

• Several neutralizing epitopes on the hMPV F protein were identified through MARM sequencing.
• Some of these epitopes map to regions homologous to those on the RSV F protein.
• Notably, overlap was observed with the epitope targeted by the RSV-neutralizing mAb palivizumab.

Conclusions:

• The study identified conserved neutralizing epitopes between hMPV and RSV F proteins.
• These conserved regions likely play critical, conserved roles in the function of both viruses.
• Findings may inform the development of broader antiviral strategies targeting related paramyxoviruses.